# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-009339
Filing Date
2024-03-26
Accepted
2024-03-26 08:11:05
Documents
18
Period of Report
2024-05-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | sava20240104_def14a.htm iXBRL | DEF 14A | 659413
6 |  | graph01.jpg | GRAPHIC | 54097
7 |  | p01.jpg | GRAPHIC | 113427
8 |  | p02.jpg | GRAPHIC | 147320
9 |  | smlogo.jpg | GRAPHIC | 13290
| Complete submission text file | 0001437749-24-009339.txt |  | 2186999

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | sava-20231231.xsd | EX-101.SCH | 7489
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | sava-20231231_def.xml | EX-101.DEF | 9573
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sava-20231231_lab.xml | EX-101.LAB | 19436
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sava-20231231_pre.xml | EX-101.PRE | 9596
21 | EXTRACTED XBRL INSTANCE DOCUMENT | sava20240104_def14a_htm.xml | XML | 131044

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41905 | Film No.: 24780983
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)